A $268 million border wall contract awarded last week was the latest in a series of big-dollar contracts in Arizona, but it was the first to raise suspicions of improper ...

Per CEO Bill Anderson in an interview this week, Bayer will have a decision in months — not years — about whether it will remain the only domestic producer of glyphosate in the U.S.

At the second attempt, the FDA has approved Citius Pharmaceuticals' marketing application for Lymphir, a new version of a lymphoma therapy withdrawn from sale several years ago.